Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

ScieGen Pharmaceuticals, a Hauppauge, New York-based generic pharmaceutical company, is voluntarily recalling in the US lots of its irbesartan tablets (USP 75 mg, 150 mg, and 300 mg), an anti-hypertension drug, to the consumer level. The recall is...

Following previously announced plans to restructure its R&D organization, Novo Nordisk has announced that a number of additional restructuring initiatives across functions and geographies have been initiated to support the commercial activities...

Johnson & Johnson (J&J) has opened a new vaccines launch facility in Leiden, the Netherlands. The facility uses technological and manufacturing platforms that can support large-scale production of vaccines for late-stage (Phase III)...

Glenmark Pharmaceuticals, a Mumbai, India-headquartered pharmaceutical company, plans to open its first US manufacturing facility in Monroe, North Carolina on October 30, 2018. The Monroe, North Carolina facility is Glenmark’s first manufacturing...

GlaxoSmithKline (GSK) has opened a £54-million ($69-million) active pharmaceutical ingredient (API) production building at its site in Montrose, Scotland for respiratory inhalers. APIs for use in GSK’s Ellipta (fluticasone furoate/vilanterol)...

As part of Pfizer’s previously announced reorganization, the company plans to reduce its global headcount by around 2% through voluntary retirements and staff reductions this year (2018) and in early 2019. Pfizer says the move is expected to...